202 related articles for article (PubMed ID: 30026606)
21. Telomere length and the risk of cutaneous malignant melanoma in melanoma-prone families with and without CDKN2A mutations.
Burke LS; Hyland PL; Pfeiffer RM; Prescott J; Wheeler W; Mirabello L; Savage SA; Burdette L; Yeager M; Chanock S; De Vivo I; Tucker MA; Goldstein AM; Yang XR
PLoS One; 2013; 8(8):e71121. PubMed ID: 23990928
[TBL] [Abstract][Full Text] [Related]
22. The relationship between telomerase activity and proliferation in cutaneous melanoma.
Zamolo G; Coklo M; Bosnar A; Batinac T
Med Hypotheses; 2007; 68(1):125-7. PubMed ID: 16891062
[TBL] [Abstract][Full Text] [Related]
23. The relationship between leukocyte telomere length and TERT, TRF1 single nucleotide polymorphisms in healthy people of different age groups.
Gedvilaite G; Vilkeviciute A; Kriauciuniene L; Banevičius M; Liutkeviciene R
Biogerontology; 2020 Feb; 21(1):57-67. PubMed ID: 31646401
[TBL] [Abstract][Full Text] [Related]
24. Telomeres and Telomere Length: A General Overview.
Srinivas N; Rachakonda S; Kumar R
Cancers (Basel); 2020 Feb; 12(3):. PubMed ID: 32121056
[TBL] [Abstract][Full Text] [Related]
25. Mutations in the promoter of the telomerase gene
Chiba K; Lorbeer FK; Shain AH; McSwiggen DT; Schruf E; Oh A; Ryu J; Darzacq X; Bastian BC; Hockemeyer D
Science; 2017 Sep; 357(6358):1416-1420. PubMed ID: 28818973
[No Abstract] [Full Text] [Related]
26. Risk Factors of Subsequent Primary Melanomas in Austria.
Müller C; Wendt J; Rauscher S; Sunder-Plassmann R; Richtig E; Fae I; Fischer G; Okamoto I
JAMA Dermatol; 2019 Feb; 155(2):188-195. PubMed ID: 30566178
[TBL] [Abstract][Full Text] [Related]
27. Telomere length and pancreatic cancer: a case-control study.
Skinner HG; Gangnon RE; Litzelman K; Johnson RA; Chari ST; Petersen GM; Boardman LA
Cancer Epidemiol Biomarkers Prev; 2012 Nov; 21(11):2095-100. PubMed ID: 23093543
[TBL] [Abstract][Full Text] [Related]
28. Telomere length, arsenic exposure and risk of basal cell carcinoma of skin.
Srinivas N; Rachakonda S; Hielscher T; Calderazzo S; Rudnai P; Gurzau E; Koppova K; Fletcher T; Kumar R
Carcinogenesis; 2019 Jul; 40(6):715-723. PubMed ID: 30874287
[TBL] [Abstract][Full Text] [Related]
29. Telomere length in peripheral blood predicts survival in clear cell renal cell carcinoma.
Svenson U; Ljungberg B; Roos G
Cancer Res; 2009 Apr; 69(7):2896-901. PubMed ID: 19318563
[TBL] [Abstract][Full Text] [Related]
30. Telomere dysfunction: a potential cancer predisposition factor.
Wu X; Amos CI; Zhu Y; Zhao H; Grossman BH; Shay JW; Luo S; Hong WK; Spitz MR
J Natl Cancer Inst; 2003 Aug; 95(16):1211-8. PubMed ID: 12928346
[TBL] [Abstract][Full Text] [Related]
31. Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer.
Broberg K; Björk J; Paulsson K; Höglund M; Albin M
Carcinogenesis; 2005 Jul; 26(7):1263-71. PubMed ID: 15746160
[TBL] [Abstract][Full Text] [Related]
32. Effects of water, sanitation, handwashing, and nutritional interventions on telomere length among children in a cluster-randomized controlled trial in rural Bangladesh.
Lin A; Arnold BF; Mertens AN; Lin J; Benjamin-Chung J; Ali S; Hubbard AE; Stewart CP; Shoab AK; Rahman MZ; Hossen MS; Mutsuddi P; Famida SL; Akther S; Rahman M; Unicomb L; Dhabhar FS; Fernald LCH; Colford JM; Luby SP
Elife; 2017 Oct; 6():. PubMed ID: 28980942
[TBL] [Abstract][Full Text] [Related]
33. The load of short telomeres is increased and associated with lifetime number of depressive episodes in bipolar II disorder.
Elvsåshagen T; Vera E; Bøen E; Bratlie J; Andreassen OA; Josefsen D; Malt UF; Blasco MA; Boye B
J Affect Disord; 2011 Dec; 135(1-3):43-50. PubMed ID: 21880373
[TBL] [Abstract][Full Text] [Related]
34. No association between telomere length-related loci and number of cutaneous nevi.
Li X; Liang G; Du M; De Vivo I; Nan H
Oncotarget; 2016 Dec; 7(50):82396-82399. PubMed ID: 27637081
[TBL] [Abstract][Full Text] [Related]
35. Prediction and monitoring of relapse in stage III melanoma using circulating tumor DNA.
Tan L; Sandhu S; Lee RJ; Li J; Callahan J; Ftouni S; Dhomen N; Middlehurst P; Wallace A; Raleigh J; Hatzimihalis A; Henderson MA; Shackleton M; Haydon A; Mar V; Gyorki DE; Oudit D; Dawson MA; Hicks RJ; Lorigan P; McArthur GA; Marais R; Wong SQ; Dawson SJ
Ann Oncol; 2019 May; 30(5):804-814. PubMed ID: 30838379
[TBL] [Abstract][Full Text] [Related]
36. Heterogeneity in tertiary lymphoid structure B-cells correlates with patient survival in metastatic melanoma.
Lynch KT; Young SJ; Meneveau MO; Wages NA; Engelhard VH; Slingluff CL; Mauldin IS
J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34103353
[TBL] [Abstract][Full Text] [Related]
37. Short leukocyte telomere length, alone and in combination with smoking, contributes to increased risk of gastric cancer or esophageal squamous cell carcinoma.
Pan W; Du J; Shi M; Jin G; Yang M
Carcinogenesis; 2017 Jan; 38(1):12-18. PubMed ID: 27797826
[TBL] [Abstract][Full Text] [Related]
38. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
[TBL] [Abstract][Full Text] [Related]
39. Change in peripheral blood leukocyte telomere length and mortality in breast cancer survivors.
Duggan C; Risques R; Alfano C; Prunkard D; Imayama I; Holte S; Baumgartner K; Baumgartner R; Bernstein L; Ballard-Barbash R; Rabinovitch P; McTiernan A
J Natl Cancer Inst; 2014 Apr; 106(4):dju035. PubMed ID: 24627273
[TBL] [Abstract][Full Text] [Related]
40. Molecular staging of malignant melanoma: correlation with clinical outcome.
Shivers SC; Wang X; Li W; Joseph E; Messina J; Glass LF; DeConti R; Cruse CW; Berman C; Fenske NA; Lyman GH; Reintgen DS
JAMA; 1998 Oct; 280(16):1410-5. PubMed ID: 9801000
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
